2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months OldDelayed Emergence from Anesthesia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Residual CurarizationNot yet recruitingPhase 42026-03-17NCT07477132
Vulnerability and Risk of Neuropathic Pain in CancerNeurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cancer, neoplasm, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorderRecruitingNot applicable2025-12-08NCT06511674